{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/42292-017#drug","name":"Spironolactone and Hydrochlorothiazide","alternateName":"spironolactone and hydrochlorothiazide","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"42292-017"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA086513"},{"@type":"PropertyValue","propertyID":"UNII","value":"0J48LPH2TH|27O7W4T232"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"f2a4fbc0-650b-440d-9555-c1720fe0fe35"}],"activeIngredient":"HYDROCHLOROTHIAZIDE, SPIRONOLACTONE","administrationRoute":["ORAL"],"dosageForm":"TABLET","manufacturer":{"@type":"Organization","name":"Mylan Institutional Inc."},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/ANDA086513","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f2a4fbc0-650b-440d-9555-c1720fe0fe35","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42292-017"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T07:47:14.804Z"}}